NCT06870162

Brief Summary

The investigators aim to conduct an open pilot trial to determine the initial feasibility of a self-directed writing-based intervention in individuals with chronic musculoskeletal pain and elevated pain catastrophizing. The investigators will assess the feasibility of recruitment, acceptability of the treatment, credibility and participant satisfaction, treatment adherence, and feasibility of assessments following pre-specified benchmarks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Oct 2025Jun 2026

First Submitted

Initial submission to the registry

March 5, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 11, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

October 14, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

April 21, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

March 5, 2025

Last Update Submit

April 17, 2026

Conditions

Keywords

pain catastrophizing

Outcome Measures

Primary Outcomes (6)

  • Feasibility of recruitment

    \>70% participants approached agree to participate in the intervention

    Baseline, post-test (6 weeks)

  • Acceptability of treatment

    \>70% of participants attend at least 6 out of 8 sessions

    Baseline, post-test (6 weeks)

  • Credibility and Expectancy Questionnaire

    Measures perception that the treatment is credible and will offer improvements. Credibility (4 items) is rated from 1-9 with higher scores indicating more credibility. Expectancy is rated from 0-10 with higher scores indicating greater expectancy of improvement.

    Baseline

  • Client Satisfaction Questionnaire

    Measure of client satisfaction with a program or intervention. 8-item scale measured from 1 to 4 with greater scores indicating greater satisfaction.

    Post-test (6 weeks)

  • Adherence to intervention

    Percent of writing sections demonstrate correct themes (e.g., anxiety words in imaginal exposure writing)

    Mid-intervention

  • Feasibility of assessments

    \>70% of participants have no measures fully missing

    Baseline, post-test (6 weeks)

Secondary Outcomes (15)

  • Numerical Rating Scale

    Baseline, post-test (6 weeks)

  • Graded Chronic Pain Scale

    Baseline, post-test (6 weeks)

  • PROMIS Pain Interference scale

    Baseline, post-test (6 weeks)

  • Brief Pain Inventory

    Baseline, post-test (6 weeks)

  • Patient Health Questionnaire - 9

    Baseline, post-test (6 weeks)

  • +10 more secondary outcomes

Study Arms (1)

Pain Disengagement Training

EXPERIMENTAL

The intervention involves approximately 8 sessions. The first session will involve a psychoeducation component describing the association between negative emotions and pain and the rationale for the intervention strategies. The intervention sessions will consist of approximately 30 minutes of writing alternating between imaginal exposure writing and positive writing periods alternating back and forth (e.g., 3-5 minutes of imaginal exposure writing followed by 3-5 minutes of positive writing before returning to imaginal exposure writing, etc.). Exposure writing will involve writing about a pain-related catastrophic worry repeatedly until it becomes less anxiety-provoking. The positive writing topics will change with each prompt and will be structured by session theme (e.g., values/goals, meaningful activities). They will also complete between session practice by setting aside a time for worrying and then completing a meaningful activity.

Behavioral: Pain Disengagement Training

Interventions

The intervention involves approximately 8 sessions. The first session will involve a psychoeducation component describing the association between negative emotions and pain and the rationale for the intervention strategies. The intervention sessions will consist of approximately 30 minutes of writing alternating between imaginal exposure writing and positive writing periods alternating back and forth (e.g., 3-5 minutes of imaginal exposure writing followed by 3-5 minutes of positive writing before returning to imaginal exposure writing, etc.). Exposure writing will involve writing about a pain-related catastrophic worry repeatedly until it becomes less anxiety-provoking. The positive writing topics will change with each prompt and will be structured by session theme (e.g., values/goals, meaningful activities). They will also complete between session practice by setting aside a time for worrying and then completing a meaningful activity.

Pain Disengagement Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatient adults (i.e., greater than or equal to 18)
  • Has self reported chronic musculoskeletal pain (i.e., pain persisting for at least 3 months)
  • Pain score greater than or equal to 4 (moderate) on the Numerical Rating Scale
  • Pain catastrophizing score greater than or equal to 20 on Pain Catastrophizing Scale
  • Willingness to engage in a writing-based intervention and self-reported ability to write or type for at least 30 minutes in a sitting
  • Received care at Massachusetts General Hospital
  • English verbal and writing fluency

You may not qualify if:

  • Clinically significant change in therapy or medication in the past 3 months
  • Severe untreated mental health condition (e.g., psychosis)
  • Active suicidality with history of plan or current intent
  • Serious illness expected to worsen in the next 6 months (e.g., cancer)
  • Untreated substance use problem that, per patient's self-report, would interfere with the ability to complete the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

Study Officials

  • Katherine McDermott, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Katherine McDermott, PhD

CONTACT

Ana-Maria Vranceanu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff psychologist

Study Record Dates

First Submitted

March 5, 2025

First Posted

March 11, 2025

Study Start

October 14, 2025

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

April 21, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified data will include feasibility assessments, intervention measures (i.e., peak emotion during writing periods) and pre and post intervention self-report questionnaires in the open pilot.

Shared Documents
SAP, ANALYTIC CODE
Time Frame
Data from this study will be deposited into the repositories no later than the end of the funded project period. Data will be available indefinitely and will only be removed from the repository if requested by NIH or other relevant institution policy.
Access Criteria
Data will be stored in the Vivli repository, an NIH-approved independent, generalist global data-sharing and analytics platform. Researchers will be able to access the data by request. Investigators will need to provide evidence of their institution's IRB approval for planned analyses of the data and upon the contingency that data only be used for research and secured by electronic safeguards. Further, this agreement will state that data will be destroyed once data analysis is complete.
More information

Locations